Clinical-stage stem cell and regenerative medicine firm Cynata has four trials underway, three ending between late this year ...

Raiden (ASX:RDN) has deepened its understanding of Andover South after completing a preliminary structural analysis of its ...

Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast.

Among the small caps in the hot Brazilian rare earths space, there’s one that’s taking a lead in the race to a non-Chinese ...

Strata Minerals (ASX:SMX) has significantly boosted its exploration portfolio by completing the acquisition of the Penny ...

There’s no shortage of junior gold explorers and developers on the ASX but what Astral Resources is sitting on is ...

Lower inflation means higher real returns for stocks. Market risk premium and Alpha are also important concepts for investors ...